Adolescents and vaccines in the western world (Q38136802)

29 August 2017

Adolescents and vaccines in the western world (English)

1 reference

29 August 2017

2

1 reference

29 August 2017

1

Nicola Principi

1 reference

PubMed ID

24029116

29 August 2017

language of work or name

English

0 references

publication date

9 September 2013

1 reference

29 August 2017

1 reference

29 August 2017

31

1 reference

29 August 2017

5366-5374

1 reference

29 August 2017

46

1 reference

Childhood vaccination successes, yes, but the job is not finished

29 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Adolescents are the orphans of immunization practices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Vaccine-preventable diseases, immunizations, and the Epidemic Intelligence Service.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Booster vaccinations: can immunologic memory outpace disease pathogenesis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

A review of clinical trials of human papillomavirus prophylactic vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Measles outbreak in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Update on adolescent immunizations: selected review of US recommendations and literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Sex differences in physiological reactivity to acute psychosocial stress in adolescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Childhood internalizing behaviour: analysis and implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Measles elimination efforts and 2008-2011 outbreak, France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Virulence factors of Bordetella pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Pertussis: the disease and the vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Rationale for pertussis booster vaccination throughout life in Europe.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Epidemic pertussis in 2012--the resurgence of a vaccine-preventable disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Clinical definitions of pertussis: Summary of a Global Pertussis Initiative roundtable meeting, February 2011

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Bordetella pertussis strain variation and evolution postvaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Waning protection after fifth dose of acellular pertussis vaccine in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Waning immunity to pertussis following 5 doses of DTaP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Long-term pertussis-specific immunity after primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Pertussis control: time for something new?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Early Impact of the US Tdap vaccination program on pertussis trends.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

The impact of adolescent pertussis immunization, 2004-2009: lessons from Australia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Economic considerations for pertussis booster vaccination in adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Pertussis re-emergence in the post-vaccination era

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Global epidemiology of meningococcal disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Meningococcal carriage by age: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Adolescents need a booster of serogroup C meningococcal vaccine to protect them and maintain population control of the disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Global burden of human papillomavirus and related diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Clinical trials of human papillomavirus vaccines and beyond

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

HPV vaccine recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

HPV vaccination among adolescent males: results from the National Immunization Survey-Teen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Delivering adolescent vaccinations in the medical home: a new era?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Legal basis of consent for health care and vaccination for adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Adolescents' access to care: teenagers' self-reported use of services and perceived access to confidential care.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Health information-seeking behaviour in adolescence: the place of the internet.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Knowledge of human papillomavirus infection and its prevention among adolescents and parents in the greater Milan area, Northern Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Pediatrician knowledge and attitudes regarding human papillomavirus disease and its prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Limited awareness of vaccines recommended for adolescents and other results from two national consumer health surveys in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Teenagers' understandings of and attitudes towards vaccines and vaccine-preventable diseases: a qualitative study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Understanding attitudes toward adolescent vaccination and the decision-making dynamic among adolescents, parents and providers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Factors that influence parental vaccination decisions for adolescents, 13 to 17 years old: National Immunization Survey-Teen, 2010.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

U.K. parents' decision-making about measles-mumps-rubella (MMR) vaccine 10 years after the MMR-autism controversy: a qualitative analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Reasons for not vaccinating adolescents: National Immunization Survey of Teens, 2008-2010.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Physician and parent opinions. Are children becoming pincushions from immunizations?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Influential factors in HPV vaccination uptake among providers in four states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

A randomized trial of the effect of centralized reminder/recall on immunizations and preventive care visits for adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Text4Health: impact of text message reminder-recalls for pediatric and adolescent immunizations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

Uptake of meningococcal vaccine in Arizona schoolchildren after implementation of school-entry immunization requirements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.092

10.1016/J.VACCINE.2013.08.092

7 January 2021

Identifiers

DOI

1 reference

29 August 2017

1 reference

PubMed ID

24029116